Friday, August 30, 2013

Study: Type 2 diabetic patients treated with DPP-4 linagliptin experience reductions in blood glucose levels

›
Data published in The   Lancet showed that elderly people with Type 2  Diabetes  (T2D) treated for 24 weeks with the dipeptidyl peptidase-...
Wednesday, August 28, 2013

Watermelon juice relieves post-exercise muscle soreness

›
Encarna Aguayo and colleagues cite past research on watermelon juice's antioxidant properties and its potential to increase mus...
Tuesday, August 27, 2013

Combined therapy could repair and prevent damage in Duchenne muscular dystrophy, study suggests

›
Results from a clinical trial of eteplirsen, { RNA, [P-deoxy-P-(dimethylamino)](2',3'-dideoxy-2',3'-imino-2',3'-se...
Monday, August 26, 2013

New approach in the treatment of breast cancer

›
Scientists at the MedUni Vienna, in collaboration with a working group led by Nancy Hynes at the University of Basel, have discovered a ne...
Sunday, August 25, 2013

GLENMARK-A new way for a new world « New Drug Approvals

›
Undiminished zest.. “Every year we expect two more molecules to get into clinical trials,” says Saldanha, his zest undiminished by ...
1 comment:
Friday, August 23, 2013

New treatment for brittle bone disease found

›
We know that,  Risedronic acid  (see structure) ( INN ) or  risedronate sodium  ( USAN ) is a  bisphosphonate  used to strengthen  bone , ...
Thursday, August 22, 2013

New role for Tamoxifen in saving high-risk breast cancer patients

›
In continuation of my update on Tamoxifen ... New role for Tamoxifen in saving high-risk breast cancer patients Ref :  http://jco.asco...
Wednesday, August 21, 2013

New designer compound JQ1, treats heart failure by targeting cell nucleus

›
Researchers from Case Western Reserve University School of Medicine and the Dana-Farber Cancer Institute have made a fundamental discov...

Scripps Florida Scientists Devise New Way to Dramatically Raise RNA Treatment Potency

›
"We're trying to make tools that can target any RNA motif," said Matthew Disney, a TSRI associate professor who authored the...
Tuesday, August 20, 2013

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

›
The UCLA researchers, led by David Eisenberg, director of the UCLA-Department of Energy Institute of Genomics and Proteomics and a Ho...
Monday, August 19, 2013

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

›
In continuation of my update on  Eltrombopag Eltrombopag  ( codenamed SB-497115-GR) is a  medication  that has been developed for c...
Friday, August 16, 2013

Rapamycin: Limited anti-aging effects

›
In continuation of my update on Rapamycin The drug rapamycin is known to increase lifespan in mice. Whether rapamycin slows down aging, ...
Thursday, August 15, 2013

Teduglutide offers relief for patients with short-bowel syndrome

›
  In continuation of my update on Teduglutide Teduglutide  (brand names  Gattex  and  Revestive ) is a 36-membered poly peptide  and...
Wednesday, August 14, 2013

Chelsea Therapeutics Announces FDA Acceptance of Northera (droxidopa) NDA Resubmission

›
In continuation of my update on  droxidopa ..... Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the U.S....
Tuesday, August 13, 2013

Cheaper anti-cancer drug as effective as expensive drug in treating most common cause of blindness in older adults

›
Results of a two-year trial, led by Queen's scientist Professor Usha Chakravarthy, and published in   The Lancet  today (Friday 19 Jul...